Altered lymphoid development in mice deficient for the mAF4 proto-oncogene

Citation
P. Isnard et al., Altered lymphoid development in mice deficient for the mAF4 proto-oncogene, BLOOD, 96(2), 2000, pp. 705-710
Citations number
45
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
96
Issue
2
Year of publication
2000
Pages
705 - 710
Database
ISI
SICI code
0006-4971(20000715)96:2<705:ALDIMD>2.0.ZU;2-D
Abstract
Some chromosomal translocations in acute leukemias involve the fusion of th e trithorax-related protein MII (also called HRX, All1, Htrx,) with a varie ty of heterologous proteins. In acute lymphoblastic leukemia associated wit h the t(4;11)(q21; q23) translocation, the 4q21 gene that fuses with MII is AF4, To gain insight into the potential role of AF4 in leukemogenesis and development, this gene was inactivated by homologous recombination in mice. As expected from the tissue distribution of the AF4 transcript, developmen t of both B and T cells is affected in AF4 mutant mice. A severe reduction of the thymic double positive CD4/CD8 (CD4(+)/CD8(+)) population was observ ed; in addition most double- and single-positive cells expressed lower leve ls of CD4 and CD8 coreceptors, Most importantly, the reconstitution of the double-positive compartment by expansion of the double-negative cell compar tment was severely impaired in these mutant mice. In the bone marrow pre-B and mature B-cell numbers are reduced. These results demonstrate that the f unction of the mAF4 gene is critical for normal lymphocyte development. Thi s raises the possibility that the disruption of the normal AF4 gene or its association with MII function by translocation may orient the oncogenic pro cess toward the lymphoid lineage. This represents the first functional stud y using a knock-out strategy on one of the Mil partner genes in translocati on-associated leukemias.